{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:23:15Z","timestamp":1790108595690,"version":"4.0.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T00:00:00Z","timestamp":1688774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T00:00:00Z","timestamp":1688774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Subsidy of the Medical University of Bialystok","award":["SUB\/1\/DN\/22\/007\/4406"],"award-info":[{"award-number":["SUB\/1\/DN\/22\/007\/4406"]}]},{"name":"Voice Analysis for Medical Professionals","award":["POIR.04.01.04-00-0052\/18"],"award-info":[{"award-number":["POIR.04.01.04-00-0052\/18"]}]},{"name":"Grant financed by Polish National Science Centre","award":["2019\/33\/B\/ST6\/02386"],"award-info":[{"award-number":["2019\/33\/B\/ST6\/02386"]}]},{"name":"Excellence Initiative - Research University"},{"name":"Center for artificial intelligence at the Medical University of Bialystok"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Metabolomics combined with machine learning methods (MLMs), is a powerful tool for searching novel diagnostic panels. This study was intended to use targeted plasma metabolomics and advanced MLMs to develop strategies for diagnosing brain tumors. Measurement of 188 metabolites was performed on plasma samples collected from 95 patients with gliomas (grade I\u2013IV), 70 with meningioma, and 71 healthy individuals as a control group. Four predictive models to diagnose glioma were prepared using 10 MLMs and a conventional approach. Based on the cross-validation results of the created models, the F1-scores were calculated, then obtained values were compared. Subsequently, the best algorithm was applied to perform five comparisons involving gliomas, meningiomas, and controls. The best results were obtained using the newly developed hybrid evolutionary heterogeneous decision tree (EvoHDTree) algorithm, which was validated using Leave-One-Out Cross-Validation, resulting in an F1-score for all comparisons in the range of 0.476\u20130.948 and the area under the ROC curves ranging from 0.660 to 0.873. Brain tumor diagnostic panels were constructed with unique metabolites, which reduces the likelihood of misdiagnosis. This study proposes a novel interdisciplinary method for brain tumor diagnosis based on metabolomics and EvoHDTree, exhibiting significant predictive coefficients.<\/jats:p>","DOI":"10.1038\/s41598-023-38243-1","type":"journal-article","created":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T10:02:04Z","timestamp":1688810524000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["A comparison of different machine-learning techniques for the selection of a panel of metabolites allowing early detection of brain tumors"],"prefix":"10.1038","volume":"13","author":[{"given":"Adrian","family":"Godlewski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Czajkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrycja","family":"Mojsak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Pienkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wioleta","family":"Gosk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Lyson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zenon","family":"Mariak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Reszec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Kondraciuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol","family":"Kaminski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Kretowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Moniuszko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Kretowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Ciborowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,8]]},"reference":[{"key":"38243_CR1","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1021\/acs.jproteome.8b00663","volume":"18","author":"L Zhou","year":"2019","unstructured":"Zhou, L. et al. Integrated metabolomics and lipidomics analyses reveal metabolic reprogramming in human glioma with IDH1 mutation. J. Proteome Res. 18, 960\u2013969. https:\/\/doi.org\/10.1021\/acs.jproteome.8b00663 (2019).","journal-title":"J. Proteome Res."},{"key":"38243_CR2","doi-asserted-by":"publisher","first-page":"188721","DOI":"10.1016\/j.bbcan.2022.188721","volume":"1877","author":"T Pienkowski","year":"2022","unstructured":"Pienkowski, T., Kowalczyk, T., Garcia-Romero, N., Ayuso-Sacido, A. & Ciborowski, M. Proteomics and metabolomics approach in adult and pediatric glioma diagnostics. Biochim. Biophys. Acta Rev. Cancer 1877, 188721. https:\/\/doi.org\/10.1016\/j.bbcan.2022.188721 (2022).","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"38243_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.7812\/TPP\/08-027","volume":"12","author":"MS Walid","year":"2008","unstructured":"Walid, M. S. Prognostic factors for long-term survival after glioblastoma. Perm. J. 12, 45\u201348. https:\/\/doi.org\/10.7812\/TPP\/08-027 (2008).","journal-title":"Perm. J."},{"key":"38243_CR4","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis, D. N. et al. The 2021 WHO classification of tumors of the central nervous system: A summary. Neuro Oncol. 23, 1231\u20131251. https:\/\/doi.org\/10.1093\/neuonc\/noab106 (2021).","journal-title":"Neuro Oncol."},{"key":"38243_CR5","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1586\/erm.12.30","volume":"12","author":"H Zong","year":"2012","unstructured":"Zong, H., Verhaak, R. G. & Canoll, P. The cellular origin for malignant glioma and prospects for clinical advancements. Expert. Rev. Mol. Diagn. 12, 383\u2013394. https:\/\/doi.org\/10.1586\/erm.12.30 (2012).","journal-title":"Expert. Rev. Mol. Diagn."},{"key":"38243_CR6","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1021\/acs.jproteome.0c00243","volume":"19","author":"J Jothi","year":"2020","unstructured":"Jothi, J., Janardhanam, V. A. & Krishnaswamy, R. Metabolic variations between low-grade and high-grade gliomas-profiling by. J. Proteome Res. 19, 2483\u20132490. https:\/\/doi.org\/10.1021\/acs.jproteome.0c00243 (2020).","journal-title":"J. Proteome Res."},{"key":"38243_CR7","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s11060-010-0386-3","volume":"99","author":"J Wiemels","year":"2010","unstructured":"Wiemels, J., Wrensch, M. & Claus, E. B. Epidemiology and etiology of meningioma. J. Neurooncol. 99, 307\u2013314. https:\/\/doi.org\/10.1007\/s11060-010-0386-3 (2010).","journal-title":"J. Neurooncol."},{"key":"38243_CR8","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.2217\/fon-2018-0006","volume":"14","author":"RA Buerki","year":"2018","unstructured":"Buerki, R. A. et al. An overview of meningiomas. Future Oncol. 14, 2161\u20132177. https:\/\/doi.org\/10.2217\/fon-2018-0006 (2018).","journal-title":"Future Oncol."},{"key":"38243_CR9","unstructured":"Meningioma: Statistics Cancer.Net, Available at: https:\/\/www.cancer.net\/cancer-types\/meningioma\/statistics. Accessed 16 November 2022."},{"key":"38243_CR10","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.biocel.2017.05.022","volume":"89","author":"A Colquhoun","year":"2017","unstructured":"Colquhoun, A. Cell biology-metabolic crosstalk in glioma. Int. J. Biochem. Cell Biol. 89, 171\u2013181. https:\/\/doi.org\/10.1016\/j.biocel.2017.05.022 (2017).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"38243_CR11","doi-asserted-by":"publisher","first-page":"20164","DOI":"10.1074\/jbc.M111.337196","volume":"287","author":"M Cuperlovic-Culf","year":"2012","unstructured":"Cuperlovic-Culf, M., Ferguson, D., Culf, A., Morin, P. & Touaibia, M. 1H NMR metabolomics analysis of glioblastoma subtypes: Correlation between metabolomics and gene expression characteristics. J. Biol. Chem. 287, 20164\u201320175. https:\/\/doi.org\/10.1074\/jbc.M111.337196 (2012).","journal-title":"J. Biol. Chem."},{"key":"38243_CR12","doi-asserted-by":"publisher","first-page":"100907","DOI":"10.1016\/j.tranon.2020.100907","volume":"14","author":"Y Xie","year":"2021","unstructured":"Xie, Y. et al. Early lung cancer diagnostic biomarker discovery by machine learning methods. Transl Oncol. 14, 100907. https:\/\/doi.org\/10.1016\/j.tranon.2020.100907 (2021).","journal-title":"Transl Oncol."},{"key":"38243_CR13","doi-asserted-by":"publisher","first-page":"20486","DOI":"10.18632\/oncotarget.7974","volume":"7","author":"H Zhao","year":"2016","unstructured":"Zhao, H. et al. Metabolomics profiling in plasma samples from glioma patients correlates with tumor phenotypes. Oncotarget 7, 20486\u201320495. https:\/\/doi.org\/10.18632\/oncotarget.7974 (2016).","journal-title":"Oncotarget"},{"key":"38243_CR14","doi-asserted-by":"publisher","first-page":"e4234","DOI":"10.1002\/nbm.4234","volume":"33","author":"V Righi","year":"2020","unstructured":"Righi, V. et al. A metabolomic data fusion approach to support gliomas grading. NMR Biomed. 33, e4234. https:\/\/doi.org\/10.1002\/nbm.4234 (2020).","journal-title":"NMR Biomed."},{"key":"38243_CR15","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1021\/acs.jproteome.9b00521","volume":"19","author":"L Bender","year":"2020","unstructured":"Bender, L. et al. Metabolomic profile of aggressive meningiomas by using high-resolution magic angle spinning nuclear magnetic resonance. J. Proteome Res. 19, 292\u2013299. https:\/\/doi.org\/10.1021\/acs.jproteome.9b00521 (2020).","journal-title":"J. Proteome Res."},{"key":"38243_CR16","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3390\/cancers14020312","volume":"14","author":"PZ Gory\u0144ska","year":"2022","unstructured":"Gory\u0144ska, P. Z. et al. Metabolomic phenotyping of gliomas: What can we get with simplified protocol for intact tissue analysis?. Cancers Basel 14, 321. https:\/\/doi.org\/10.3390\/cancers14020312 (2022).","journal-title":"Cancers Basel"},{"key":"38243_CR17","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1158\/1541-7786.MCR-20-0548","volume":"19","author":"KL Penney","year":"2021","unstructured":"Penney, K. L. et al. Metabolomics of prostate cancer gleason score in tumor tissue and serum. Mol. Cancer Res. 19, 475\u2013484. https:\/\/doi.org\/10.1158\/1541-7786.MCR-20-0548 (2021).","journal-title":"Mol. Cancer Res."},{"key":"38243_CR18","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s11306-019-1612-4","volume":"15","author":"KM Mendez","year":"2019","unstructured":"Mendez, K. M., Reinke, S. N. & Broadhurst, D. I. A comparative evaluation of the generalised predictive ability of eight machine learning algorithms across ten clinical metabolomics data sets for binary classification. Metabolomics 15, 150. https:\/\/doi.org\/10.1007\/s11306-019-1612-4 (2019).","journal-title":"Metabolomics"},{"key":"38243_CR19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1088\/0951-7715\/21\/8\/t03","volume":"21","author":"M Francesco","year":"2008","unstructured":"Francesco, M. et al. Some nonlinear challenges in biology. Nonlinearity 21, 131\u2013147. https:\/\/doi.org\/10.1088\/0951-7715\/21\/8\/t03 (2008).","journal-title":"Nonlinearity"},{"key":"38243_CR20","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1021\/acs.jproteome.7b00595","volume":"17","author":"FM Alakwaa","year":"2018","unstructured":"Alakwaa, F. M., Chaudhary, K. & Garmire, L. X. Deep learning accurately predicts estrogen receptor status in breast cancer metabolomics data. J. Proteome Res. 17, 337\u2013347. https:\/\/doi.org\/10.1021\/acs.jproteome.7b00595 (2018).","journal-title":"J. Proteome Res."},{"key":"38243_CR21","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/s11306-019-1609-z","volume":"15","author":"SC Cheng","year":"2019","unstructured":"Cheng, S. C. et al. Metabolomic biomarkers in cervicovaginal fluid for detecting endometrial cancer through nuclear magnetic resonance spectroscopy. Metabolomics 15, 146. https:\/\/doi.org\/10.1007\/s11306-019-1609-z (2019).","journal-title":"Metabolomics"},{"key":"38243_CR22","doi-asserted-by":"publisher","first-page":"3629","DOI":"10.1021\/acs.jproteome.1c00213","volume":"20","author":"OO Bifarin","year":"2021","unstructured":"Bifarin, O. O. et al. Machine learning-enabled renal cell carcinoma status prediction using multiplatform urine-based metabolomics. J. Proteome Res. 20, 3629\u20133641. https:\/\/doi.org\/10.1021\/acs.jproteome.1c00213 (2021).","journal-title":"J. Proteome Res."},{"key":"38243_CR23","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/odi.13591","volume":"27","author":"VL Kouznetsova","year":"2021","unstructured":"Kouznetsova, V. L., Li, J., Romm, E. & Tsigelny, I. F. Finding distinctions between oral cancer and periodontitis using saliva metabolites and machine learning. Oral Dis. 27, 484\u2013493. https:\/\/doi.org\/10.1111\/odi.13591 (2021).","journal-title":"Oral Dis."},{"key":"38243_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/lci2.25","volume":"2","author":"CE Hershberger","year":"2021","unstructured":"Hershberger, C. E. et al. Salivary metabolites are promising non-invasive biomarkers of hepatocellular carcinoma and chronic liver disease. Liver Cancer Int. 2, 33\u201344. https:\/\/doi.org\/10.1002\/lci2.25 (2021).","journal-title":"Liver Cancer Int."},{"key":"38243_CR25","doi-asserted-by":"publisher","unstructured":"Czajkowski, M., Jurczuk, K. & Kretowski, M. Accelerated evolutionary induction of heterogeneous decision trees for gene expression-based classification. In Proceedings of the Genetic and Evolutionary Computation Conference (Association for Computing Machinery, Lille, France, 2021). https:\/\/doi.org\/10.1145\/3449639.3459376.","DOI":"10.1145\/3449639.3459376"},{"key":"38243_CR26","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1109\/TEVC.2013.2291813","volume":"18","author":"RC Barros","year":"2014","unstructured":"Barros, R. C., Basgalupp, M. P., Freitas, A. A. & de-Carvalho, A. C. P. L. F. Evolutionary design of decision-tree algorithms tailored to microarray gene expression data sets. IEEE Trans. Evol. Comput. 18, 873\u2013892. https:\/\/doi.org\/10.1109\/TEVC.2013.2291813 (2014).","journal-title":"IEEE Trans. Evol. Comput."},{"key":"38243_CR27","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/s11596-021-2356-8","volume":"41","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y. et al. Distinguishing rectal cancer from colon cancer based on the support vector machine method and rna-sequencing data. Curr. Med. Sci. 41, 368\u2013374. https:\/\/doi.org\/10.1007\/s11596-021-2356-8 (2021).","journal-title":"Curr. Med. Sci."},{"key":"38243_CR28","doi-asserted-by":"publisher","first-page":"748061","DOI":"10.3389\/fonc.2021.748061","volume":"11","author":"D Lin","year":"2021","unstructured":"Lin, D. et al. Trends in intracranial glioma incidence and mortality in the United States, 1975\u20132018. Front. Oncol. 11, 748061. https:\/\/doi.org\/10.3389\/fonc.2021.748061 (2021).","journal-title":"Front. Oncol."},{"key":"38243_CR29","first-page":"3425","volume":"11","author":"T Pienkowski","year":"2021","unstructured":"Pienkowski, T., Kowalczyk, T., Kretowski, A. & Ciborowski, M. A review of gliomas-related proteins. Characteristics of potential biomarkers. Am. J. Cancer Res. 11, 3425\u20133444 (2021).","journal-title":"Am. J. Cancer Res."},{"key":"38243_CR30","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3390\/metabo11030133","volume":"11","author":"AD Rogachev","year":"2021","unstructured":"Rogachev, A. D. et al. Correlation of metabolic profiles of plasma and cerebrospinal fluid of high-grade glioma patients. Metabolites 11, 133. https:\/\/doi.org\/10.3390\/metabo11030133 (2021).","journal-title":"Metabolites"},{"key":"38243_CR31","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1002\/mc.22694","volume":"56","author":"R Pandey","year":"2017","unstructured":"Pandey, R., Caflisch, L., Lodi, A., Brenner, A. J. & Tiziani, S. Metabolomic signature of brain cancer. Mol. Carcinog. 56, 2355\u20132371. https:\/\/doi.org\/10.1002\/mc.22694 (2017).","journal-title":"Mol. Carcinog."},{"key":"38243_CR32","doi-asserted-by":"publisher","first-page":"10546","DOI":"10.1093\/nar\/gky889","volume":"46","author":"N Rappoport","year":"2018","unstructured":"Rappoport, N. & Shamir, R. Multi-omic and multi-view clustering algorithms: Review and cancer benchmark. Nucleic Acids Res. 46, 10546\u201310562. https:\/\/doi.org\/10.1093\/nar\/gky889 (2018).","journal-title":"Nucleic Acids Res."},{"key":"38243_CR33","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3390\/metabo12040357","volume":"12","author":"Y Chen","year":"2022","unstructured":"Chen, Y., Li, E. M. & Xu, L. Y. Guide to metabolomics analysis: A bioinformatics workflow. Metabolites 12, 357. https:\/\/doi.org\/10.3390\/metabo12040357 (2022).","journal-title":"Metabolites"},{"key":"38243_CR34","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41422-022-00614-0","volume":"32","author":"Y Xiao","year":"2022","unstructured":"Xiao, Y. et al. Comprehensive metabolomics expands precision medicine for triple-negative breast cancer. Cell Res. 32, 477\u2013490. https:\/\/doi.org\/10.1038\/s41422-022-00614-0 (2022).","journal-title":"Cell Res."},{"key":"38243_CR35","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.csbj.2020.05.021","volume":"18","author":"J Gal","year":"2020","unstructured":"Gal, J. et al. Comparison of unsupervised machine-learning methods to identify metabolomic signatures in patients with localized breast cancer. Comput. Struct. Biotechnol. J 18, 1509\u20131524. https:\/\/doi.org\/10.1016\/j.csbj.2020.05.021 (2020).","journal-title":"Comput. Struct. Biotechnol. J"},{"key":"38243_CR36","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.3390\/diagnostics11071281","volume":"11","author":"N Li","year":"2021","unstructured":"Li, N. et al. Combination of plasma-based metabolomics and machine learning algorithm provides a novel diagnostic strategy for malignant mesothelioma. Diagn. Basel 11, 1281. https:\/\/doi.org\/10.3390\/diagnostics11071281 (2021).","journal-title":"Diagn. Basel"},{"key":"38243_CR37","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1038\/s41467-020-17347-6","volume":"11","author":"L Huang","year":"2020","unstructured":"Huang, L. et al. Machine learning of serum metabolic patterns encodes early-stage lung adenocarcinoma. Nat. Commun. 11, 3556. https:\/\/doi.org\/10.1038\/s41467-020-17347-6 (2020).","journal-title":"Nat. Commun."},{"key":"38243_CR38","doi-asserted-by":"publisher","first-page":"e666","DOI":"10.1002\/ctm2.666","volume":"12","author":"VM Prade","year":"2022","unstructured":"Prade, V. M. et al. The synergism of spatial metabolomics and morphometry improves machine learning-based renal tumour subtype classification. Clin. Transl. Med. 12, e666. https:\/\/doi.org\/10.1002\/ctm2.666 (2022).","journal-title":"Clin. Transl. Med."},{"key":"38243_CR39","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1038\/s41598-022-06274-9","volume":"12","author":"A Gupta","year":"2022","unstructured":"Gupta, A. et al. A non-invasive method for concurrent detection of early-stage women-specific cancers. Sci. Rep. 12, 2301. https:\/\/doi.org\/10.1038\/s41598-022-06274-9 (2022).","journal-title":"Sci. Rep."},{"key":"38243_CR40","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cca.2021.03.021","volume":"519","author":"W Wang","year":"2021","unstructured":"Wang, W., He, Z., Kong, Y., Liu, Z. & Gong, L. GC-MS-based metabolomics reveals new biomarkers to assist the differentiation of prostate cancer and benign prostatic hyperplasia. Clin. Chim. Acta 519, 10\u201317. https:\/\/doi.org\/10.1016\/j.cca.2021.03.021 (2021).","journal-title":"Clin. Chim. Acta"},{"key":"38243_CR41","doi-asserted-by":"publisher","first-page":"112520","DOI":"10.1016\/j.rser.2022.112520","volume":"165","author":"I Adilkhanova","year":"2022","unstructured":"Adilkhanova, I., Ngarambe, J. & Yun, G. Y. Recent advances in black box and white-box models for urban heat island prediction: Implications of fusing the two methods. Renew. Sustain. Energy Rev. 165, 112520. https:\/\/doi.org\/10.1016\/j.rser.2022.112520 (2022).","journal-title":"Renew. Sustain. Energy Rev."},{"key":"38243_CR42","doi-asserted-by":"publisher","first-page":"e0217348","DOI":"10.1371\/journal.pone.0217348","volume":"14","author":"TA Pontes","year":"2019","unstructured":"Pontes, T. A., Barbosa, A. D., Silva, R. D., Melo-Junior, M. R. & Silva, R. O. Osteopenia-osteoporosis discrimination in postmenopausal women by 1H NMR-based metabonomics. PLoS ONE 14, e0217348. https:\/\/doi.org\/10.1371\/journal.pone.0217348 (2019).","journal-title":"PLoS ONE"},{"key":"38243_CR43","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.ygeno.2019.05.024","volume":"112","author":"B Niu","year":"2020","unstructured":"Niu, B. et al. Glioma stages prediction based on machine learning algorithm combined with protein-protein interaction networks. Genomics 112, 837\u2013847. https:\/\/doi.org\/10.1016\/j.ygeno.2019.05.024 (2020).","journal-title":"Genomics"},{"key":"38243_CR44","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1021\/acs.jproteome.0c00697","volume":"20","author":"Y Shi","year":"2021","unstructured":"Shi, Y. et al. Integrative analysis of metabolomic and transcriptomic data reveals metabolic alterations in glioma patients. J. Proteome Res. 20, 2206\u20132215. https:\/\/doi.org\/10.1021\/acs.jproteome.0c00697 (2021).","journal-title":"J. Proteome Res."},{"key":"38243_CR45","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s00726-020-02931-3","volume":"53","author":"EJ Bobeff","year":"2021","unstructured":"Bobeff, E. J. et al. Plasma amino acids indicate glioblastoma with ATRX loss. Amino Acids 53, 119\u2013132. https:\/\/doi.org\/10.1007\/s00726-020-02931-3 (2021).","journal-title":"Amino Acids"},{"key":"38243_CR46","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/sj.bjc.6604933","volume":"100","author":"KS Opstad","year":"2009","unstructured":"Opstad, K. S., Bell, B. A., Griffiths, J. R. & Howe, F. A. Taurine: A potential marker of apoptosis in gliomas. Br. J. Cancer 100, 789\u2013794. https:\/\/doi.org\/10.1038\/sj.bjc.6604933 (2009).","journal-title":"Br. J. Cancer"},{"key":"38243_CR47","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1016\/j.biocel.2012.06.025","volume":"44","author":"P Tripathi","year":"2012","unstructured":"Tripathi, P. et al. Delineating metabolic signatures of head and neck squamous cell carcinoma: Phospholipase A2, a potential therapeutic target. Int. J. Biochem. Cell Biol. 44, 1852\u20131861. https:\/\/doi.org\/10.1016\/j.biocel.2012.06.025 (2012).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"38243_CR48","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1080\/1028415x.2001.11747379","volume":"4","author":"L Lima","year":"2001","unstructured":"Lima, L., Obregon, F., Cubillos, S., Fazzino, F. & Jaimes, I. Taurine as a micronutrient in development and regeneration of the central nervous system. Nutr. Neurosci. 4, 439\u2013443. https:\/\/doi.org\/10.1080\/1028415x.2001.11747379 (2001).","journal-title":"Nutr. Neurosci."},{"key":"38243_CR49","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1158\/1541-7786.MCR-20-0086","volume":"19","author":"TM Thomas","year":"2021","unstructured":"Thomas, T. M. et al. Elevated asparagine biosynthesis drives brain tumor stem cell metabolic plasticity and resistance to oxidative stress. Mol. Cancer Res. 19, 1375\u20131388. https:\/\/doi.org\/10.1158\/1541-7786.MCR-20-0086 (2021).","journal-title":"Mol. Cancer Res."},{"key":"38243_CR50","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12944-021-01581-y","volume":"20","author":"H Tallima","year":"2021","unstructured":"Tallima, H., Azzazy, H. M. E. & El Ridi, R. Cell surface sphingomyelin: Key role in cancer initiation, progression, and immune evasion. Lipids Health Dis. 20, 150. https:\/\/doi.org\/10.1186\/s12944-021-01581-y (2021).","journal-title":"Lipids Health Dis."},{"key":"38243_CR51","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3390\/cancers12010111","volume":"12","author":"MN Tea","year":"2020","unstructured":"Tea, M. N., Poonnoose, S. I. & Pitson, S. M. Targeting the sphingolipid system as a therapeutic direction for glioblastoma. Cancers (Basel) 12, 111. https:\/\/doi.org\/10.3390\/cancers12010111 (2020).","journal-title":"Cancers (Basel)"},{"key":"38243_CR52","doi-asserted-by":"publisher","first-page":"109957","DOI":"10.1016\/j.celrep.2021.109957","volume":"37","author":"J Bi","year":"2021","unstructured":"Bi, J. et al. Targeting glioblastoma signaling and metabolism with a re-purposed brain-penetrant drug. Cell Rep. 37, 109957. https:\/\/doi.org\/10.1016\/j.celrep.2021.109957 (2021).","journal-title":"Cell Rep."},{"key":"38243_CR53","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/s41392-021-00808-9","volume":"6","author":"L Du","year":"2021","unstructured":"Du, L. et al. Correction: Both IDO1 and TDO contribute to the malignancy of gliomas via the Kyn\u2013AhR\u2013AQP4 signaling pathway. Signal Transduct. Target. Ther. 6, 385. https:\/\/doi.org\/10.1038\/s41392-021-00808-9 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"38243_CR54","doi-asserted-by":"publisher","first-page":"102075","DOI":"10.1016\/j.canep.2021.102075","volume":"76","author":"CM Samanic","year":"2022","unstructured":"Samanic, C. M. et al. A prospective study of pre-diagnostic circulating tryptophan and kynurenine, and the kynurenine\/tryptophan ratio and risk of glioma. Cancer Epidemiol. 76, 102075. https:\/\/doi.org\/10.1016\/j.canep.2021.102075 (2022).","journal-title":"Cancer Epidemiol."},{"key":"38243_CR55","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.3389\/fonc.2019.01455","volume":"9","author":"JA Hulin","year":"2019","unstructured":"Hulin, J. A. et al. Inhibition of dimethylarginine dimethylaminohydrolase (DDAH) enzymes as an emerging therapeutic strategy to target angiogenesis and vasculogenic mimicry in cancer. Front. Oncol. 9, 1455. https:\/\/doi.org\/10.3389\/fonc.2019.01455 (2019).","journal-title":"Front. Oncol."},{"key":"38243_CR56","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/s41591-019-0423-5","volume":"25","author":"Z Wang","year":"2019","unstructured":"Wang, Z. et al. Methionine is a metabolic dependency of tumor-initiating cells. Nat. Med. 25, 825\u2013837. https:\/\/doi.org\/10.1038\/s41591-019-0423-5 (2019).","journal-title":"Nat. Med."},{"key":"38243_CR57","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1152\/physrev.2000.80.3.1107","volume":"80","author":"M Wyss","year":"2000","unstructured":"Wyss, M. & Kaddurah-Daouk, R. Creatine and creatinine metabolism. Physiol. Rev. 80, 1107\u20131213. https:\/\/doi.org\/10.1152\/physrev.2000.80.3.1107 (2000).","journal-title":"Physiol. Rev."},{"key":"38243_CR58","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/(sici)1099-1492(199701)10:1<2::aid-nbm442>3.0.co;2-n","volume":"10","author":"Y Kinoshita","year":"1997","unstructured":"Kinoshita, Y. & Yokota, A. Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy. NMR Biomed. 10, 2\u201312. https:\/\/doi.org\/10.1002\/(sici)1099-1492(199701)10:1%3c2::aid-nbm442%3e3.0.co;2-n (1997).","journal-title":"NMR Biomed."},{"key":"38243_CR59","doi-asserted-by":"publisher","first-page":"625417","DOI":"10.3389\/fphys.2021.625417","volume":"12","author":"W das-Neves","year":"2021","unstructured":"das-Neves, W., Alves, C. R. R., de-Souza-Borges, A. P. & de-Castro, G. Serum creatinine as a potential biomarker of skeletal muscle atrophy in non-small cell lung cancer patients. Front. Physiol. 12, 625417. https:\/\/doi.org\/10.3389\/fphys.2021.625417 (2021).","journal-title":"Front. Physiol."},{"key":"38243_CR60","doi-asserted-by":"publisher","first-page":"14783","DOI":"10.1038\/s41598-018-32847-8","volume":"8","author":"W Li","year":"2018","unstructured":"Li, W. et al. Glycerophosphatidylcholine PC(36:1) absence and 3\u2032-phosphoadenylate (pAp) accumulation are hallmarks of the human glioma metabolome. Sci. Rep. 8, 14783. https:\/\/doi.org\/10.1038\/s41598-018-32847-8 (2018).","journal-title":"Sci. Rep."},{"key":"38243_CR61","doi-asserted-by":"publisher","first-page":"478","DOI":"10.3390\/metabo10120478","volume":"10","author":"D Yu","year":"2020","unstructured":"Yu, D. et al. Metabolic alterations related to glioma grading based on metabolomics and lipidomics analyses. Metabolites 10, 478. https:\/\/doi.org\/10.3390\/metabo10120478 (2020).","journal-title":"Metabolites"},{"key":"38243_CR62","doi-asserted-by":"publisher","first-page":"8426","DOI":"10.1158\/0008-5472.CAN-10-1498","volume":"70","author":"D Monle\u00f3n","year":"2010","unstructured":"Monle\u00f3n, D. et al. Metabolic aggressiveness in benign meningiomas with chromosomal instabilities. Cancer Res. 70, 8426\u20138434. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-1498 (2010).","journal-title":"Cancer Res."},{"key":"38243_CR63","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1002\/iub.2149","volume":"71","author":"E Baranovi\u010dov\u00e1","year":"2019","unstructured":"Baranovi\u010dov\u00e1, E. et al. Metabolomic profiling of blood plasma in patients with primary brain tumours: Basal plasma metabolites correlated with tumour grade and plasma biomarker analysis predicts feasibility of the successful statistical discrimination from healthy subjects\u2014a p. IUBMB Life 71, 1994\u20132002. https:\/\/doi.org\/10.1002\/iub.2149 (2019).","journal-title":"IUBMB Life"},{"key":"38243_CR64","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1093\/neuonc\/noab219","volume":"24","author":"OB Ijare","year":"2022","unstructured":"Ijare, O. B. et al. Glutamine anaplerosis is required for amino acid biosynthesis in human meningiomas. Neuro Oncol. 24, 556\u2013568. https:\/\/doi.org\/10.1093\/neuonc\/noab219 (2022).","journal-title":"Neuro Oncol."},{"key":"38243_CR65","doi-asserted-by":"publisher","first-page":"721","DOI":"10.3171\/2019.11.JNS192028","volume":"134","author":"D Yamashita","year":"2020","unstructured":"Yamashita, D. et al. Targeting glioma-initiating cells via the tyrosine metabolic pathway. J. Neurosurg. 134, 721\u2013732. https:\/\/doi.org\/10.3171\/2019.11.JNS192028 (2020).","journal-title":"J. Neurosurg."},{"key":"38243_CR66","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3390\/metabo11080507","volume":"11","author":"S Firdous","year":"2021","unstructured":"Firdous, S. et al. Dysregulated alanine as a potential predictive marker of glioma-an insight from untargeted HRMAS-NMR and machine learning data. Metabolites 11, 507. https:\/\/doi.org\/10.3390\/metabo11080507 (2021).","journal-title":"Metabolites"},{"key":"38243_CR67","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jocn.2019.07.078","volume":"68","author":"JE Lee","year":"2019","unstructured":"Lee, J. E. et al. Metabolic profiling of human gliomas assessed with NMR. J. Clin. Neurosci. 68, 275\u2013280. https:\/\/doi.org\/10.1016\/j.jocn.2019.07.078 (2019).","journal-title":"J. Clin. Neurosci."},{"key":"38243_CR68","doi-asserted-by":"publisher","first-page":"928","DOI":"10.3174\/ajnr.A7462","volume":"43","author":"AG Osborn","year":"2022","unstructured":"Osborn, A. G., Louis, D. N., Poussaint, T. Y., Linscott, L. L. & Salzman, K. L. The 2021 World Health Organization classification of tumors of the central nervous system: What neuroradiologists need to know. AJNR Am. J. Neuroradiol. 43, 928\u2013937. https:\/\/doi.org\/10.3174\/ajnr.A7462 (2022).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"38243_CR69","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis, D. N. et al. The 2016 World Health Organization classification of tumors of the central nervous system: A summary. Acta Neuropathol. 131, 803\u2013820. https:\/\/doi.org\/10.1007\/s00401-016-1545-1 (2016).","journal-title":"Acta Neuropathol."},{"key":"38243_CR70","doi-asserted-by":"publisher","first-page":"5074","DOI":"10.3390\/jcm10215074","volume":"10","author":"E Sawicka-Smiarowska","year":"2021","unstructured":"Sawicka-Smiarowska, E. et al. Gut microbiome in chronic coronary syndrome patients. J. Clin. Med. 10, 5074. https:\/\/doi.org\/10.3390\/jcm10215074 (2021).","journal-title":"J. Clin. Med."},{"key":"38243_CR71","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1016\/j.bbe.2021.10.005","volume":"41","author":"D Reska","year":"2021","unstructured":"Reska, D. et al. Integration of solutions and services for multi-omics data analysis towards personalized medicine. Biocybern. Biomed. Eng. 41, 1646\u20131663. https:\/\/doi.org\/10.1016\/j.bbe.2021.10.005 (2021).","journal-title":"Biocybern. Biomed. Eng."},{"key":"38243_CR72","volume-title":"Predictive Analytics and Data Mining: Concepts and Practice with Rapidminer","author":"V Kotu","year":"2014","unstructured":"Kotu, V. & Deshpande, B. Predictive Analytics and Data Mining: Concepts and Practice with Rapidminer (Morgan Kaufmann, 2014)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-38243-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-38243-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-38243-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T10:05:03Z","timestamp":1688810703000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-38243-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,8]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["38243"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-38243-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,8]]},"assertion":[{"value":"23 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11044"}}